School of Medicine


Showing 141-160 of 174 Results

  • Mariana Schmajuk

    Mariana Schmajuk

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Mariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.

    Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee.

  • Shebani Sethi Dalai MD

    Shebani Sethi Dalai MD

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Clinical and academic interests are in the management of psychiatric disorders with co-morbid obesity and treatment of eating disorders, particularly binge eating disorder and bulimia nervosa. Improving metabolic and mental health through dietary interventions, pharmacological optimization, and other lifestyle means in those with severe mental illness is another major focus of her research.

  • Ripal Shah

    Ripal Shah

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Ripal Shah, M.D., M.P.H. is a Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pregnancy, postpartum, breastfeeding, infertility, PMDD, sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, minerals, supplements, exercise, behavioral modifications), and in physician wellness (the WellConnect program - serving Stanford resident and fellow physicians).

    Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, diversity & inclusion program development, the intersection of race and sexuality, ethnicity-dependent variability in mental health treatment response, and minority stress. Outside of consultations, she specializes in psychotherapy for LGBTQ and minority populations, particularly those struggling with issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status), as well as cognitive-behavioral therapy for ADHD and anxiety disorders.

    While in training at Stanford, she served as Chief Resident and led Community Partnerships and Diversity & Inclusion efforts. She consistently ranked #1 in the entire Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, most recently in California after the wildfires, in Florida after Hurricane Irma and Maria, and in Kathmandu following the Nepal earthquake. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for training programs across the country, built and then graduated from a Diversity & Health Equity track in the residency training program, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents? Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at the Harvard School of Public Health in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York, and a B.S. from Duke University in Economics and Biochemistry. She is board certified in Adult Psychiatry and board eligible in Addiction Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine.

  • Yelizaveta Sher

    Yelizaveta Sher

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as a Mental Health Coordinator for the Adult Cystic Fibrosis Clinic.

  • Hugh Brent Solvason PhD MD

    Hugh Brent Solvason PhD MD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests My work is focused on novel interventional treatment approaches for treatment resistant unipolar and bipolar depression. We are currently enrolling patients with treatment refractory bipolar depression for a radiosurgical neuromodulation study. We are awaiting the start of enrollment for a DBS in unipolar depression study.
    I am also working with children in Sub Saharan Africa. Primarily I am focused on methods to assess well-being, and long term outcomes for these vulnerable children.

  • Barbara Sommer

    Barbara Sommer

    Associate Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emerita

    Current Research and Scholarly Interests I am interested in the clinical investigation of cognitive stresses during younger adulthood that may give rise to frank intellectual impairment with older age. Examples may include specific kinds of chronically taken medications.

  • Trisha Suppes, MD, PhD

    Trisha Suppes, MD, PhD

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    Current Research and Scholarly Interests Long-term treatment strategies for bipolar disorder, treatment for bipolar II disorder, use of treatment algorithms, and treatment of major depression.

  • Julie Half Sutcliffe

    Julie Half Sutcliffe

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Julie Sutcliffe is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She began at Stanford in 2018. Prior to Stanford, she was employed by Northwestern University as a clinical and sport psychologist.

  • Allison Thompson, Ph.D.

    Allison Thompson, Ph.D.

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.

  • Aubrey Michelle Toole, PhD

    Aubrey Michelle Toole, PhD

    Academic Staff - Hourly, Psychiatry and Behavioral Sciences

    Bio Dr. Aubrey Toole is a licensed psychologist whose research and clinical work has focused on the treatment and prevention of eating and body image problems and the potential benefits of compassion- and acceptance-based interventions. Dr. Toole further specializes in treating eating and body image concerns in high performance athletes at Stanford. She also serves as a supervisor within the PGSP-Stanford Psy.D. Consortium. She completed her bachelor?s degree in Psychology with Highest Honors at UC Berkeley and her Ph.D. in Clinical Psychology at Emory University. She completed her predoctoral internship at Emory University?s School of Medicine and postdoctoral fellowship at Stanford University?s School of Medicine.

  • Mickey Trockel

    Mickey Trockel

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Mickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.

    Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations.

  • Peter Johannes van Roessel

    Peter Johannes van Roessel

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr Peter van Roessel, M.D. Ph.D, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University, where he provided clinical care for individuals participating in research studies across a spectrum of psychiatric illness, including treatment resistant mood disorders, anxiety disorders, psychosis and substance use disorders.

    At Stanford, he sees adult mood and anxiety disorders outpatients through the Evaluations Clinic and Depression Clinic and participates in resident training and patient care as a supervisor in psychodynamic psychotherapy and as an attending physician in Continuity Clinic. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment, and contributes to clinical neuroscience studies pioneering rapid-acting interventions in OCD.

    Dr van Roessel pursued research training basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology in the laboratory of Dr Andrea Brand at the University of Cambridge, UK. More recently, he has contributed to work in the lab of Dr Julia Kaltschmidt (Sloan Kettering Institute, now Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. In the Rodriguez Lab, he is pursuing clinically-motivated research interests related to the nature and neural correlates of insight in obsessive-compulsive and related disorders. He has additionally received a 2018 NARSAD Young Investigator Award to pursue a novel glutamatergic rapid-acting treatment for OCD.

Footer Links:

Stanford Medicine Resources: